Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients.

Saved in:
Bibliographic Details
Title: Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients.
Authors: Sokolenko, Anna P.1,2 (AUTHOR), Moiseyenko, Fedor V.3 (AUTHOR), Iyevleva, Aglaya G.1,2 (AUTHOR), Ivantsov, Alexandr O.1 (AUTHOR), Dolmatov, Georgiy D.3 (AUTHOR), Shelekhova, Ksenia V.3 (AUTHOR), Gulo, Elizaveta V.3 (AUTHOR), Topal, Anastasya X.3 (AUTHOR), Artemieva, Elizaveta V.3 (AUTHOR), Abduloeva, Nuriniso H.3 (AUTHOR), Rysev, Nikita A.3 (AUTHOR), Barsova, Daria A.3 (AUTHOR), Levchenko, Natalia V.3 (AUTHOR), Volkov, Nikita M.3 (AUTHOR), Egorenkov, Vitaliy V.3 (AUTHOR), Moiseyenko, Vladimir M.3 (AUTHOR), Imyanitov, Evgeny N.1,2,3 (AUTHOR) evgeny@imyanitov.spb.ru
Source: International Journal of Molecular Sciences. Feb2023, Vol. 24 Issue 3, p1870. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms24031870